Last quarter (Q3 2024), Portage Biotech Inc's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, Portage Biotech Inc's net income was $-39.37M. See Portage Biotech Inc’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19
Total Revenue	-	-	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Cost of Revenue	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-
Operating Expense	$ 14.74M	$ 16.58M	$ 15.59M	$ 12.44M	$ 5.98M	$ 2.76M
Operating Income	$ -14.74M	$ -16.58M	$ -15.59M	$ -12.44M	$ -5.98M	$ -2.76M
Net Non Operating Interest Income Expense	$ 50.00K	-	$ -43.00K	$ -177.00K	$ -546.00K	$ 23.00K
Other Income Expense	$ -3.01M	$ -2.48M	$ 814.00K	$ -2.27M	$ 15.00K	$ -853.00K
Pretax Income	$ -60.25M	$ -122.52M	$ -14.82M	$ -14.89M	$ -6.51M	$ -3.59M
Tax Provision	$ -8.21M	$ -17.86M	$ 4.35M	$ 2.30M	$ 740.00K	$ 0.00
Earnings From Equity Interest Net Of Tax	$ -176.00K	$ -260.00K	-	-	-	-
Net Income Common Stockholders	$ -52.02M	$ -104.61M	$ -16.87M	$ -15.83M	$ -5.33M	$ -2.63M
Basic EPS	$ -2.61	$ -6.49	$ -1.29	$ -1.35	$ -0.49	$ -0.55
Diluted EPS	$ -2.61	$ -6.49	$ -1.29	$ -1.35	$ -0.49	$ -0.55
Basic Average Shares	$ 55.74M	$ 16.12M	$ 13.06M	$ 11.73M	$ 10.95M	$ 4.82M
Diluted Average Shares	$ 55.74M	$ 16.12M	$ 13.06M	$ 11.73M	$ 10.95M	$ 4.82M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 14.74M	$ 16.58M	$ 15.59M	$ 12.44M	$ 5.98M	$ 2.76M
Interest Expense	-	-	$ 43.00K	$ 177.00K	$ 557.00K	$ 88.00K
Net Income From Continuing And Discontinued Operation	$ -52.02M	$ -104.61M	$ -16.87M	$ -15.83M	$ -5.33M	$ -2.63M
Normalized Income	$ -7.22M	-	$ -17.40M	$ -15.44M	$ -5.33M	$ -1.94M
EBIT	$ -5.30M	-	$ -14.77M	$ -14.71M	$ -5.95M	$ -3.51M
EBITDA	$ -5.30M	-	$ -14.77M	$ -14.71M	$ -5.95M	$ -3.51M

Currency in USD

Portage Biotech Inc Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing